S&P 500
5,975.35
+0.7%
+$39.41
DJI
42,495.59
+0.4%
+$190.11
NASDAQ
19,446.48
+1.1%
+$203.86
Bitcoin
106,374.00
+2.1%
+2,189.47
AAPL
$203.08
+0.7%
+$1.38
AMZN
$207.83
+0.6%
+$1.18
GOOG
$169.32
-0.6%
-$1.05
META
$670.79
-0.0%
-$0.11
MSFT
$462.80
+0.2%
+$0.83
NVDA
$141.73
+3.2%
+$4.35
TSLA
$354.68
+3.5%
+$11.99
Coeptis Therapeutics (NASDAQ: COEP)
$9.52
(2.4%)
$0.22
Price as of June 3, 2025, 12:20 p.m. ET
Coeptis Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Coeptis Therapeutics Company Info
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.